We have located links that may give you full text access.
Autophagy-Inhibition potentiates cell death and its Activation by trehalose does not protect hippocampal HT22 neurons against cell death induced by ER-Stress.
Current Neurovascular Research 2019 January 32
ER stress leads to the activation of two protein degradation pathways, the ubiquitin-proteasome via ER-associated degradation and lysosome-mediated protein degradation via autophagy. ER-associated degradation involves translocation of unfolded ER proteins to the cytosol where they are ubiquitinated and degraded by the proteasome. When the accumulation of misfolded or unfolded proteins excels the ER capacity, autophagy can be activated in order to degrade accumulated proteins and thus attenuate ER stress. Autophagy is the process by which cellular macromolecules and organelles components are sequestered within double membrane vesicles and delivered to lysosomes for degradation and recycling of bioenergetics substrate. Initially, autophagy in response to ER stress acts as a survival response, functioning to degrade misfolded and aggregated proteins, as well as damaged organelles. However, like the ER stress response, while a limited amount of stress will induce a protective response, when the stress is more pronounced the response will trigger cell death. Because autophagy could exert both anti- and pro-apoptotic activities depending on the conditions, we examined the effects autophagy modulation on ER stress-induced cell death in HT22 murine hippocampal neuronal cells. We investigated the effects of both autophagy-inhibition by 3-MA and autophagy-activation by trehalose on ER-stress induced damage in hippocampal HT22 neurons. We evaluated the expression of ER stress- and autophagy-sensors as well as the neuronal viability. Based on our findings, we conclude that under ER-stress conditions, inhibition of autophagy exacerbates cell damage and induction of autophagy by trehalose failed to be neuroprotective.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app